Suspension: SARS-CoV-2 JN.1 mRNA 50 µg pro dosi, heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas, cholesterolum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, 1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus, trometamolum, trometamoli hydrochloridum, acidum aceticum, natrii acetas trihydricus, saccharum, aqua ad iniectabile, pro dosi, natrium 0.017 mg pro dosi.
Packungsbestandteile
Dispersion zur Injektion
BAG: Active Agent
Dose
Sars-Cov-2 jn.1 Mrna
50 mcg
Inactive agents
Dose
additional_information
1,2-dimyristoyl-Rac-Glycero-3-Polyethylenglycoli
2000
1,2-distearoyl-Sn-Glycero-3-Phosphocholinum
Acetic Acid
Aether Methylicus
Cholesterol
Mrna
50 µg
Sodium Acetate Trihydrate
Sodium
0.017 mg
Saccharumaqua
Sars-Cov-2 jn.
1
Suspension
Trometamoli Hydrochloridum
Trometamol
Source
Data was imported : 12.03.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
